Bosulif works by interfering with the growth of particular cancer cells. Bosulif is administered for the treatment of Philadelphia chromosome-positive chronic myelogenous leukemia (CML), a type of blood cancer. Bosulif is given after other similar drugs have been used without success. Sometimes, Bosulif is used in other cancer types as part of clinical trials.
Drug Name: Bosulif
Generic name: Bosutinib monohydrate